Beauty Advices

American Cancer Society Shifts Stance to Recommend Routine Prostate Screening

Middle aged men are being urged to take a more proactive approach to their health following a significant update to prostate cancer screening guidelines from the American Cancer Society. In a departure from previous advice that encouraged shared decision making, the organization now recommends that men at average risk undergo a PSA blood test every two years between the ages of 50 and 69. This shift reflects a growing confidence in modern diagnostic tools and a better understanding of how to manage the results without overtreating patients.

For those in higher risk categories, including Black men and individuals with a strong family history of the disease, the recommendations are even more stringent. These men are advised to begin screening five years earlier, starting at age 45, and should opt for yearly checks rather than biennial ones. A strong family history is defined as having a father, brother, or son diagnosed before age 65, or multiple close relatives affected regardless of when they were diagnosed.

The change addresses long standing concerns regarding the PSA test, which measures a protein that can rise due to cancer but also because of non cancerous enlargement or physical exertion. While critics previously feared that routine testing led to unnecessary biopsies and aggressive treatments for slow growing tumors, medical professionals say newer protocols have mitigated these risks. Doctors now utilize repeat testing and MRI scans to confirm findings before proceeding to invasive biopsies, allowing many low risk cases to be monitored safely rather than treated immediately.

Medical experts believe this clarity will streamline conversations between patients and primary care physicians who may have found previous guidelines too ambiguous. By removing the guesswork, specialists hope more men will catch the disease in its earliest stages when it is most survivable. However, the society maintains that these suggestions are not one size fits all; men should still discuss their specific health profiles with their doctors, particularly as they reach age 70 and beyond when the benefits of continued screening become less certain.

You may also like